Skip to main content
Toggle navigation
Search
Home
7 Views
Like
Facebook
Post
Print
CRT 2026
Top Abstracts
Session:: Abstracts | Hot Topics | Diabetes, Lipid Disorders, and Risk Factor Management | Session Two
Additive Cardiorenal Benefits Of Finerenone And Sglt2 Inhibitor Combination Therapy In Diabetic Ckd: A Propensity-matched Real-world Study
Monday, March 9, 2026
2:12 PM - 2:18 PM
EST
Location: Theater #1
Speaker(s)
Ibrahim Mortada
Disclosure(s): No financial relationships to disclose